Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | chromobox homolog 1 | Starlite/ChEMBL | No references |
Homo sapiens | polo-like kinase 1 | Starlite/ChEMBL | No references |
Plasmodium falciparum | heat shock protein 90, putative | Starlite/ChEMBL | No references |
Homo sapiens | apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3D | Starlite/ChEMBL | No references |
Homo sapiens | glycoprotein hormones, alpha polypeptide | Starlite/ChEMBL | No references |
Plasmodium berghei | glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase, putative | Starlite/ChEMBL | No references |
Homo sapiens | EYA transcriptional coactivator and phosphatase 2 | Starlite/ChEMBL | No references |
Trypanosoma brucei | hypothetical protein, conserved | Starlite/ChEMBL | No references |
Homo sapiens | myeloid cell leukemia 1 | Starlite/ChEMBL | No references |
Homo sapiens | vitamin D (1,25- dihydroxyvitamin D3) receptor | Starlite/ChEMBL | No references |
Rattus norvegicus | Thioredoxin reductase 1, cytoplasmic | Starlite/ChEMBL | No references |
Bacillus subtilis | 4'-phosphopantetheinyl transferase ffp | Starlite/ChEMBL | No references |
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Schistosoma mansoni | Thioredoxin glutathione reductase | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | Hsp90 domain-containing protein | 0.0194 | 0.549 | 1 |
Onchocerca volvulus | Heterochromatin protein 1 homolog | 0.0047 | 0.0588 | 0.07 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.2827 | 0.908 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0033 | 0.0127 | 0.0409 |
Echinococcus multilocularis | Bcl 2 ous antagonist:killer | 0.01 | 0.2357 | 0.8335 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0036 | 0.0202 | 0.5 |
Mycobacterium ulcerans | glucose-6-phosphate 1-dehydrogenase | 0.0113 | 0.2778 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.01 | 0.2357 | 0.4332 |
Trichomonas vaginalis | chromobox protein, putative | 0.0084 | 0.1826 | 0.5862 |
Onchocerca volvulus | 0.0182 | 0.5117 | 1 | |
Loa Loa (eye worm) | glutathione reductase | 0.0103 | 0.245 | 0.4523 |
Toxoplasma gondii | glucose-6-phosphate 1-dehydrogenase | 0.0074 | 0.1471 | 0.24 |
Plasmodium falciparum | glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | 0.0123 | 0.3114 | 0.5507 |
Echinococcus multilocularis | glucose 6 phosphate 1 dehydrogenase | 0.0113 | 0.2778 | 0.9827 |
Trypanosoma cruzi | Glucose-6-phosphate dehydrogenase, putative | 0.0036 | 0.0222 | 0.0292 |
Leishmania major | hypothetical protein, conserved | 0.0257 | 0.7607 | 1 |
Schistosoma mansoni | bcl-2 homologous antagonist/killer (bak) | 0.01 | 0.2357 | 0.2199 |
Loa Loa (eye worm) | PLK/PLK1 protein kinase | 0.0114 | 0.2827 | 0.5299 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.2827 | 0.908 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0103 | 0.245 | 0.4251 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.0036 | 0.0202 | 0.0265 |
Toxoplasma gondii | glucose-6-phosphate 1-dehydrogenase | 0.0123 | 0.3114 | 0.5507 |
Schistosoma mansoni | hypothetical protein | 0.01 | 0.2357 | 0.2199 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0036 | 0.0202 | 0.5 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0257 | 0.7607 | 1 |
Onchocerca volvulus | 0.01 | 0.237 | 0.4359 | |
Echinococcus multilocularis | serine:threonine protein kinase PLK1 | 0.0114 | 0.2827 | 1 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0036 | 0.0202 | 0.0265 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.2827 | 0.908 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0036 | 0.0202 | 0.0265 |
Trichomonas vaginalis | chromobox protein, putative | 0.0051 | 0.0708 | 0.2274 |
Echinococcus granulosus | L aminoadipate semialdehyde | 0.01 | 0.237 | 0.8382 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase | 0.0036 | 0.0202 | 0.0727 |
Trichomonas vaginalis | chromobox protein, putative | 0.0051 | 0.0708 | 0.2274 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0114 | 0.2827 | 0.3717 |
Chlamydia trachomatis | glucose-6-phosphate 1-dehydrogenase | 0.0113 | 0.2778 | 1 |
Brugia malayi | Heterochromatin protein 1 | 0.0084 | 0.1826 | 0.3304 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0103 | 0.245 | 0.4523 |
Echinococcus granulosus | chromobox protein 1 | 0.0084 | 0.1826 | 0.6457 |
Giardia lamblia | Glucose-6-phosphate 1-dehydrogenase | 0.0123 | 0.3114 | 1 |
Schistosoma mansoni | aminoadipate-semialdehyde dehydrogenase | 0.01 | 0.237 | 0.2213 |
Giardia lamblia | Kinase, PLK | 0.0114 | 0.2827 | 0.9016 |
Echinococcus granulosus | chromobox protein 1 | 0.0084 | 0.1826 | 0.6457 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.0036 | 0.0202 | 0.0265 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0103 | 0.247 | 0.8736 |
Schistosoma mansoni | hypothetical protein | 0.01 | 0.2357 | 0.2199 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0114 | 0.2827 | 0.3717 |
Mycobacterium tuberculosis | Probable soluble pyridine nucleotide transhydrogenase SthA (STH) (NAD(P)(+) transhydrogenase [B-specific]) (nicotinamide nucleot | 0.0036 | 0.0202 | 0.0261 |
Brugia malayi | Apoptosis regulator proteins, Bcl-2 family protein | 0.01 | 0.2357 | 0.4384 |
Trypanosoma brucei | glucose-6-phosphate 1-dehydrogenase | 0.0113 | 0.2778 | 0.3479 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.0036 | 0.0202 | 0.0265 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0234 | 0.6856 | 0.8868 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase, LpdB | 0.0036 | 0.0202 | 0.0727 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0047 | 0.0588 | 0.1889 |
Leishmania major | glucose-6-phosphate 1-dehydrogenase, putative | 0.0113 | 0.2778 | 0.3652 |
Leishmania major | trypanothione reductase | 0.0103 | 0.245 | 0.322 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.2827 | 0.908 |
Trichomonas vaginalis | glucosamine-6-phosphate isomerase, putative | 0.0123 | 0.3114 | 1 |
Trichomonas vaginalis | glutathione reductase, putative | 0.0036 | 0.0202 | 0.0648 |
Entamoeba histolytica | serine/threonine protein kinase, putative | 0.0114 | 0.2827 | 0.5 |
Trypanosoma brucei | trypanothione reductase | 0.0103 | 0.245 | 0.3035 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0257 | 0.7607 | 1 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0261 | 0.7732 | 1 |
Brugia malayi | glutathione reductase | 0.0103 | 0.245 | 0.4573 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0103 | 0.245 | 0.322 |
Toxoplasma gondii | thioredoxin reductase | 0.0103 | 0.245 | 0.4251 |
Trypanosoma brucei | polo-like protein kinase | 0.0114 | 0.2827 | 0.3545 |
Echinococcus granulosus | glucose 6 phosphate 1 dehydrogenase | 0.0113 | 0.2778 | 0.9827 |
Plasmodium falciparum | glutathione reductase | 0.0103 | 0.245 | 0.4251 |
Trypanosoma cruzi | glucose-6-phosphate 1-dehydrogenase, putative | 0.0113 | 0.2778 | 0.3652 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0036 | 0.0202 | 0.0265 |
Schistosoma mansoni | chromobox protein | 0.0084 | 0.1826 | 0.1657 |
Echinococcus granulosus | serine:threonine protein kinase PLK1 | 0.0114 | 0.2827 | 1 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0234 | 0.6856 | 0.8868 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0114 | 0.2827 | 0.268 |
Trichomonas vaginalis | 6-phosphogluconolactonase, putative | 0.0123 | 0.3114 | 1 |
Mycobacterium tuberculosis | Probable reductase | 0.0234 | 0.6856 | 0.8868 |
Schistosoma mansoni | kinase | 0.0058 | 0.095 | 0.0764 |
Leishmania major | protein kinase, putative,polo-like protein kinase, putative | 0.0114 | 0.2827 | 0.3717 |
Brugia malayi | glucose-6-phosphate dehydrogenase | 0.0113 | 0.2778 | 0.5242 |
Echinococcus multilocularis | chromobox protein 1 | 0.0084 | 0.1826 | 0.6457 |
Echinococcus multilocularis | chromobox protein 1 | 0.0084 | 0.1826 | 0.6457 |
Mycobacterium ulcerans | flavoprotein disulfide reductase | 0.0036 | 0.0202 | 0.0727 |
Plasmodium vivax | glucose-6-phosphate 1-dehydrogenase, putative | 0.0123 | 0.3114 | 0.5507 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.0036 | 0.0202 | 0.0265 |
Trichomonas vaginalis | glucosamine-6-phosphate isomerase, putative | 0.0123 | 0.3114 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0033 | 0.0127 | 0.0409 |
Loa Loa (eye worm) | apoptosis regulator protein | 0.01 | 0.2357 | 0.4332 |
Loa Loa (eye worm) | hypothetical protein | 0.0106 | 0.2571 | 0.4772 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0261 | 0.7732 | 1 |
Mycobacterium ulcerans | glucose-6-phosphate 1-dehydrogenase | 0.0074 | 0.1471 | 0.5295 |
Schistosoma mansoni | hypothetical protein | 0.01 | 0.2357 | 0.2199 |
Echinococcus granulosus | Bcl 2 ous antagonist:killer | 0.01 | 0.2357 | 0.8335 |
Trypanosoma cruzi | glucose-6-phosphate 1-dehydrogenase, putative | 0.0037 | 0.0259 | 0.034 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0261 | 0.7732 | 1 |
Loa Loa (eye worm) | glucose-6-phosphate dehydrogenase | 0.0113 | 0.2778 | 0.5198 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0036 | 0.0202 | 0.0265 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0036 | 0.0202 | 0.0265 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0261 | 0.7732 | 1 |
Mycobacterium tuberculosis | Probable glucose-6-phosphate 1-dehydrogenase Zwf2 (G6PD) | 0.0039 | 0.0317 | 0.041 |
Trichomonas vaginalis | chromobox protein, putative | 0.0084 | 0.1826 | 0.5862 |
Brugia malayi | hypothetical protein | 0.0182 | 0.5117 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0056 | 0.09 | 0.2889 |
Schistosoma mansoni | eyes absent homolog | 0.0106 | 0.2571 | 0.2418 |
Leishmania major | acetoin dehydrogenase e3 component-like protein | 0.0036 | 0.0202 | 0.0265 |
Leishmania major | 2-oxoglutarate dehydrogenase, e3 component, lipoamidedehydrogenase-like protein | 0.0036 | 0.0202 | 0.0265 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0103 | 0.247 | 0.8736 |
Echinococcus granulosus | EGFP:Bcl2 fusion protein | 0.01 | 0.2357 | 0.8335 |
Echinococcus multilocularis | dihydrolipoamide dehydrogenase | 0.0036 | 0.0202 | 0.0714 |
Plasmodium vivax | heat shock protein, putative | 0.0194 | 0.549 | 1 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0234 | 0.6856 | 0.8868 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.2827 | 0.908 |
Schistosoma mansoni | apoptosis regulator bax | 0.01 | 0.2357 | 0.2199 |
Onchocerca volvulus | Serine\/threonine kinase homolog | 0.0114 | 0.2827 | 0.5299 |
Echinococcus granulosus | dihydrolipoamide dehydrogenase | 0.0036 | 0.0202 | 0.0714 |
Loa Loa (eye worm) | hypothetical protein | 0.0047 | 0.0588 | 0.07 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0234 | 0.6856 | 0.8868 |
Brugia malayi | aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase | 0.01 | 0.237 | 0.4411 |
Treponema pallidum | glucose-6-phosphate 1-dehydrogenase | 0.0113 | 0.2778 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0047 | 0.0588 | 0.1889 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0257 | 0.7607 | 1 |
Schistosoma mansoni | chromobox protein | 0.0084 | 0.1826 | 0.1657 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.2827 | 0.908 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.2827 | 0.908 |
Brugia malayi | hypothetical protein | 0.0106 | 0.2571 | 0.4821 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0036 | 0.0202 | 0.0265 |
Loa Loa (eye worm) | hypothetical protein | 0.01 | 0.237 | 0.4359 |
Echinococcus multilocularis | L aminoadipate semialdehyde | 0.01 | 0.237 | 0.8382 |
Brugia malayi | chromobox protein homolog 3 | 0.0047 | 0.0588 | 0.0786 |
Echinococcus multilocularis | EGFP:Bcl2 fusion protein | 0.01 | 0.2357 | 0.8335 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0056 | 0.09 | 0.2889 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0103 | 0.245 | 0.3168 |
Loa Loa (eye worm) | hypothetical protein | 0.0106 | 0.2571 | 0.4772 |
Loa Loa (eye worm) | hypothetical protein | 0.0182 | 0.5117 | 1 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0036 | 0.0202 | 0.0265 |
Plasmodium falciparum | thioredoxin reductase | 0.0103 | 0.245 | 0.4251 |
Plasmodium falciparum | heat shock protein 90, putative | 0.0194 | 0.549 | 1 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0234 | 0.6856 | 0.8868 |
Brugia malayi | Thioredoxin reductase | 0.0103 | 0.245 | 0.4573 |
Schistosoma mansoni | glucose-6-phosphate 1-dehydrogenase | 0.0113 | 0.2778 | 0.263 |
Trichomonas vaginalis | mercuric reductase, putative | 0.0036 | 0.0202 | 0.0648 |
Brugia malayi | serine/threonine-protein kinase plk-2 | 0.0114 | 0.2827 | 0.5342 |
Loa Loa (eye worm) | heterochromatin protein 1 | 0.0084 | 0.1826 | 0.3241 |
Plasmodium vivax | glutathione reductase, putative | 0.0103 | 0.245 | 0.4251 |
Onchocerca volvulus | Heterochromatin protein 1 homolog | 0.0051 | 0.0708 | 0.0946 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
AC50 (functional) | = 4.484 uM | PUBCHEM_BIOASSAY: Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504596] | ChEMBL. | No reference |
AC50 (functional) | = 25.638 uM | PUBCHEM_BIOASSAY: HsHsp90 Counterscreen Measured in Microorganism System Using Plate Reader - 2121-02_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504596] | ChEMBL. | No reference |
EC50 (functional) | = 59.6 uM | PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS activators of Mouse Intestinal Alkaline Phosphatase using Placental Alkaline Phosphatase. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2805, AID2817] | ChEMBL. | No reference |
EC50 (functional) | 59.7 uM | PUBCHEM_BIOASSAY: Dose Response concentration confirmation of uHTS hits from a small molecule activators of mouse intestinal alkaline phosphatase via a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2805, AID2817] | ChEMBL. | No reference |
EC50 (functional) | = 61.6 uM | PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS activators of Mouse Intestinal Alkaline Phosphatase using Tissue Nonspecific Alkaline Phosphatase. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2805, AID2817] | ChEMBL. | No reference |
EC50 (functional) | = 76.8 uM | PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS activators of Mouse Intestinal Alkaline Phosphatase using Human Intestinal Alkaline Phosphatase. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2805, AID2817] | ChEMBL. | No reference |
IC50 (functional) | = 7.9 uM | PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504690, AID504696] | ChEMBL. | No reference |
IC50 (binding) | > 12.089 um | PUBCHEM_BIOASSAY: Fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. (Class of assay: confirmatory) [Related pubchem assays: 2090 (Summary AID.), 2057 (Screening assay (MCL1 inhibitors).), 2168 (Screening assay (MCL1 inhibitors).)] | ChEMBL. | No reference |
IC50 (functional) | = 36.4 uM | PUBCHEM_BIOASSAY: Human Glucose-6-Phosphate Dehydrogenase Dose Response Selectivity Assay for Inhibitors of Plasmodium falciparum Glucose-6-Phosphate Dehydrogenase. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504690, AID504696] | ChEMBL. | No reference |
IC50 (functional) | 64.53 uM | PUBCHEM_BIOASSAY: Identification of SV40 T antigen inhibitors: A route to novel anti-viral reagents. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1909, AID2102, AID2501, AID2615, AID2775, AID449729, AID485276, AID485288] | ChEMBL. | No reference |
IC50 (functional) | > 80 uM | PUBCHEM_BIOASSAY: Dose Response orthogonal assay utilizing the direct end-point detection of NADPH for uHTS small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504690, AID504696] | ChEMBL. | No reference |
IC50 (functional) | > 80 uM | PUBCHEM_BIOASSAY: Dose Response orthogonal kinetic assay utilizing the direct detection of NADPH for uHTS small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504690, AID504696] | ChEMBL. | No reference |
IC50 (binding) | > 108.803 um | PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)] | ChEMBL. | No reference |
Potency (functional) | 1.9953 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Texas Red Assay. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 2.1192 uM | PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 2.8184 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Fluorescein Assay. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 4.2284 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 4.4668 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771] | ChEMBL. | No reference |
Potency (functional) | 5.6234 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Vif-A3F Interactions: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 6.3096 um | PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 8.4936 uM | PubChem BioAssay. qHTS for Inhibitors of the Phosphatase Activity of Eya2: Confirmatory Assay for Cherry-picked Compounds. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 14.1254 uM | PubChem BioAssay. qHTS of Trypanosoma Brucei Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 14.1254 uM | PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 15.8489 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 17.7828 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 19.9526 um | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)] | ChEMBL. | No reference |
Potency (functional) | = 19.9526 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 20.5878 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493106, AID493143] | ChEMBL. | No reference |
Potency (functional) | 20.5962 uM | PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855] | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Eta. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588636] | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PubChem BioAssay. qHTS for Inhibitors of Vif-A3G Interactions: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 23.9341 uM | PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411] | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 25.1189 uM | PubChem BioAssay. qHTS of alpha-syn Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Potency (functional) | 29.0929 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction. (Class of assay: confirmatory) [Related pubchem assays: 2698 (Summary assay.)] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of GCN5L2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504398] | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488813] | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PUBCHEM_BIOASSAY: Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504856] | ChEMBL. | No reference |
Potency (functional) | 56.2341 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Potency (functional) | 56.2341 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Kappa. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588638] | ChEMBL. | No reference |
Potency (functional) | 56.2341 uM | PubChem BioAssay. qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 63.0957 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PubChem BioAssay. qHTS for Inhibitors of WRN Helicase. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.